ATE218062T1 - Lactobazillus- und magermilchzusammensetzungenund verfahren zur verhütung der mikrobiellen urogenitalen infektionen - Google Patents

Lactobazillus- und magermilchzusammensetzungenund verfahren zur verhütung der mikrobiellen urogenitalen infektionen

Info

Publication number
ATE218062T1
ATE218062T1 AT92923265T AT92923265T ATE218062T1 AT E218062 T1 ATE218062 T1 AT E218062T1 AT 92923265 T AT92923265 T AT 92923265T AT 92923265 T AT92923265 T AT 92923265T AT E218062 T1 ATE218062 T1 AT E218062T1
Authority
AT
Austria
Prior art keywords
lactobacillus
pct
skimmed milk
compositions
urogenital infections
Prior art date
Application number
AT92923265T
Other languages
English (en)
Inventor
Gregor Dr Reid
Andrew Watt Dr Bruce
Original Assignee
Urex Biotech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10704712&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE218062(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Urex Biotech Inc filed Critical Urex Biotech Inc
Application granted granted Critical
Publication of ATE218062T1 publication Critical patent/ATE218062T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/20—Milk; Whey; Colostrum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/853—Lactobacillus
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/853—Lactobacillus
    • Y10S435/854—Lactobacillus acidophilus
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/853—Lactobacillus
    • Y10S435/855—Lactobacillus brevis
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/853—Lactobacillus
    • Y10S435/856—Lactobacillus casei
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/853—Lactobacillus
    • Y10S435/857—Lactobacillus plantarum

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Reproductive Health (AREA)
  • Developmental Biology & Embryology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT92923265T 1991-11-15 1992-11-13 Lactobazillus- und magermilchzusammensetzungenund verfahren zur verhütung der mikrobiellen urogenitalen infektionen ATE218062T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9124335A GB2261372A (en) 1991-11-15 1991-11-15 Lactobacillus and skim milk compositions for prevention of urogenital infection
PCT/CA1992/000491 WO1993009793A1 (en) 1991-11-15 1992-11-13 Lactobacillus and skim milk compositions and methods for preventing microbial urogenital infections

Publications (1)

Publication Number Publication Date
ATE218062T1 true ATE218062T1 (de) 2002-06-15

Family

ID=10704712

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92923265T ATE218062T1 (de) 1991-11-15 1992-11-13 Lactobazillus- und magermilchzusammensetzungenund verfahren zur verhütung der mikrobiellen urogenitalen infektionen

Country Status (10)

Country Link
US (2) US5645830A (de)
EP (1) EP0613374B1 (de)
AT (1) ATE218062T1 (de)
AU (1) AU2920592A (de)
CA (1) CA2123709A1 (de)
DE (1) DE69232621T2 (de)
DK (1) DK0613374T3 (de)
ES (1) ES2173872T3 (de)
GB (1) GB2261372A (de)
WO (1) WO1993009793A1 (de)

Families Citing this family (60)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA942302B (en) * 1993-12-03 1995-09-29 Lafor Lab Ltd Viracidal bactericidal and spermicidal vaginal suppository
SE9501056D0 (sv) * 1995-03-23 1995-03-23 Probi Ab Epithelial adherent lactobacilli
SE9502588L (sv) 1995-07-13 1997-01-14 Moelnlycke Ab Hämning av tillväxten av bakterier i samband med absorberande alster med hjälp av tillsats av andra bakterier
KR100376954B1 (ko) * 1995-07-31 2003-07-18 프로비 에이비 장에서집락화하는유산간균
AUPN698495A0 (en) * 1995-12-06 1996-01-04 Pharma Pacific Pty Ltd Improved therapeutic formulation and method
AU1758197A (en) * 1996-02-14 1997-09-02 Procter & Gamble Company, The Urogenital and intestinal compositions
GB2310375A (en) * 1996-02-21 1997-08-27 Vanessa Clare Mcclafferty Pessaries for treating vaginal infections
AUPN907296A0 (en) * 1996-04-02 1996-04-26 Commonwealth Scientific And Industrial Research Organisation Biocontrol agents for use in treatment of opportunistic infections
EP1728855A1 (de) * 1996-11-29 2006-12-06 Bio-K Plus International, Inc. Milchsäureferment das einen speziellen Stamm von Lactobacillus acidophilus enthält und Verwendung davon
CA2271930C (en) * 1996-11-29 2006-10-17 Bio K + International Inc. Lactic ferment comprising a particular strain of lactobacillus acidophilus and use thereof
US6093394A (en) * 1997-04-11 2000-07-25 Gynelogix, Inc. Vaginal lactobacillus medicant
US7135191B2 (en) * 1997-09-04 2006-11-14 Zsolt Istvan Hertelendy Urogenital or anorectal transmucosal vaccine delivery system
SE9703669D0 (sv) * 1997-10-08 1997-10-08 Moelnlycke Ab Alster och beredning innefattande mjölksyrabakterier
SE9800749D0 (sv) * 1998-03-06 1998-03-06 Essum Ab New agent
SE519648C2 (sv) * 1998-03-06 2003-03-25 Essum Ab Ny stam av Lactobacillus plantarum
ES2165139T3 (es) * 1998-04-30 2002-03-01 Vesely Renata Maria Cavaliere Composiciones farmaceuticas que contienen lactobacillus brevis y lactobacillus salivarius para el tratamiento de infecciones vaginales.
RU2133272C1 (ru) * 1998-06-11 1999-07-20 Акционерное общество открытого типа "Биомед" им.И.И.Мечникова Штамм бактерии lactobacillus fermentum 90-ts-4(21), используемый для получения эубиотического препарата для применения в гинекологической практике
AUPP494798A0 (en) 1998-07-29 1998-08-20 Pacific Biolink Pty Limited Protective protein formulation
US7767203B2 (en) * 1998-08-07 2010-08-03 Ganeden Biotech, Inc. Methods for the dietary management of irritable bowel syndrome and carbohydrate malabsorption
KR20010101171A (ko) * 1998-12-11 2001-11-14 추후기재 비뇨생식기 감염의 치료 및 예방을 위한 락토바실러스의경구 투여
RU2146526C1 (ru) * 1999-05-05 2000-03-20 Колокольцов Алексей Александрович Лечебно-профилактический препарат в твердой и мягкой формах и способ профилактики и лечения дисбактериоза и урогенитальных инфекций
WO2000071138A2 (en) * 1999-05-25 2000-11-30 Gregor Reid Oral administration of lactobacillus for the maintenance of health in women
CA2374938A1 (en) * 1999-05-25 2000-11-30 Gregor Reid Lactobacillus compositions and methods for preventing wound infections and biofilm formation on implantable surgical devices
US7060432B1 (en) 1999-06-15 2006-06-13 Applera Corporation Methods for the detection, identification, and/or enumeration of yeast, particularly in wine
EP1212066A4 (de) * 1999-08-09 2004-03-03 Univ Maryland Pro-intestinale reifung und entzündungshemmende wirkung des lactobacillus und der von lactobacillus sekretierten proteinen, kohlenhydraten und lipiden
US6682744B1 (en) 1999-08-09 2004-01-27 University Of Maryland Pro-gut maturation and anti-inflammatory effects of lactobacillus and lactobacillus secreted proteins, carbohydrates and lipids
SE9904289D0 (sv) * 1999-11-26 1999-11-26 Niklas Arnberg Method and camposition for the treatment of adenovairal ocular infections
US20020044926A1 (en) * 1999-12-10 2002-04-18 Gregor Reid Oral administration of lactobacillus for the treatment and prevention of urogenital infection
JP4512228B2 (ja) * 2000-03-24 2010-07-28 株式会社ヤクルト本社 尿路感染症予防治療剤
ATE419880T1 (de) * 2000-06-09 2009-01-15 Baylor College Medicine Kombination von antimikrobiellen wirkstoffen und bakterieller interferenz zum überziehen medizinischer vorrichtungen
TW588109B (en) * 2000-07-29 2004-05-21 Tcell Biotechnology Food Co Lt Lactobacillus rhamnosus strain and uses thereof
SE518097C2 (sv) 2000-10-03 2002-08-27 Ellen Ab Förfarande för framställning av en absorberande sanitetsartikel som innefattar mjölksyraproducerande bakterier samt sådant alster
SE521022C2 (sv) 2001-09-20 2003-09-23 Ellen Ab Mjölksyraproducerande bakterier för användning som probiotiska organismer i vaginan hos människa
PE20030283A1 (es) * 2001-07-26 2003-05-01 Alimentary Health Ltd Cepas de lactobacillus casei
US20030143262A1 (en) 2001-12-13 2003-07-31 Brusk Ulla Forsgren Hygiene tissue
PL212647B1 (pl) * 2002-03-21 2012-11-30 Bifodan As Kompozycja farmaceutyczna, szczep Lactobacillus paracasei Lbp PB01 oraz szczep Lactobacillus paracasei Lbp PB01 w polaczeniu ze szczepem Lactobacillus acidophilus Lba EB01, produkt chlonny zawierajacy te kompozycje oraz produkt nabialowy, produkt nutraceutyczny i czynnosciowy produkt zywnosciowy zawierajace ten szczep albo te dwa szczepy, a takze zastosowanie tego szczepu albo tych dwóch szczepów
AU2003215472A1 (en) 2002-03-28 2003-10-13 Jeremy Burton Lactobacillus iners for the enhancement of urogenital health
RU2227039C2 (ru) * 2002-07-03 2004-04-20 Алехина Галина Геннадьевна Пробиотическая композиция с высокой антагонистической активностью в отношении условно-патогенной и патогенной микрофлоры для лечебно-профилактических средств и способ ее получения
US20060233884A1 (en) * 2003-04-09 2006-10-19 Balazs Dolhay Sexual hygienic composition
US8877178B2 (en) 2003-12-19 2014-11-04 The Iams Company Methods of use of probiotic bifidobacteria for companion animals
US20050158294A1 (en) 2003-12-19 2005-07-21 The Procter & Gamble Company Canine probiotic Bifidobacteria pseudolongum
CA2572939C (en) * 2004-07-23 2011-04-26 Stephen M. Renzin Mini pad for reducing inflammation of the vulva and method of making the same
US20060062773A1 (en) * 2004-09-21 2006-03-23 The Procter & Gamble Company Compositions for maintaining and restoring normal gastrointestinal flora
WO2006045347A1 (en) * 2004-10-22 2006-05-04 Medinova Ag Lactobacillus helveticus strain useful in the treatment or prevention of infections caused by urogenital pathogens
EP1802318A1 (de) * 2004-10-22 2007-07-04 Medinova AG Milchsäurebakterien-stämme gegen gastrointestinale erreger und diese enthaltende zusammensetzungen
AU2006253006B8 (en) 2005-05-31 2011-09-15 Alimentary Health Ltd Feline probiotic Lactobacilli
CA2607949C (en) 2005-05-31 2012-09-25 Thomas William-Maxwell Boileau Feline probiotic bifidobacteria
JP2009503098A (ja) * 2005-08-04 2009-01-29 フェマシューティカルズ リミテッド ライアビリティ カンパニー おむつかぶれおよび同等物などの皮膚炎を治療するための方法
US8309076B2 (en) * 2006-08-04 2012-11-13 Bioneer Corporation Lactic acid bacteria isolated from mother's milk with probiotic activity and inhibitory activity against body weight augmentation
AU2008211600B8 (en) 2007-02-01 2014-02-13 Mars, Incorporated Method for decreasing inflammation and stress in a mammal using glucose antimetabolites, avocado or avocado extracts
US20090041727A1 (en) 2007-08-08 2009-02-12 Conjugon, Inc. Compositions and Methods for Microbe Storage and Delivery
US9771199B2 (en) 2008-07-07 2017-09-26 Mars, Incorporated Probiotic supplement, process for making, and packaging
EP2323486A4 (de) * 2008-07-30 2012-03-28 Nestec Sa Verfahren und zusammensetzungen zur prävention oder behandlung von schäden infolge von ischämie oder ischämieartigen erkrankungen
EP2158916A1 (de) 2008-08-27 2010-03-03 Ellen Aktiebolag Milchsäurebakterien enthaltende Verabreichungseinheit
JP5836264B2 (ja) 2009-04-29 2015-12-24 ガネーデン バイオテック インコーポレイテッド 不活性化細菌細胞製剤
US10104903B2 (en) 2009-07-31 2018-10-23 Mars, Incorporated Animal food and its appearance
EP2953476B1 (de) * 2013-02-07 2020-01-01 Novozymes A/S Verwendung von magermilch als träger für eine zusammensetzung mit lactobacillus
EP3548045B1 (de) 2016-11-30 2024-06-12 Probioswiss AG Zusammensetzungen zur verwindung in der behandlung von urogenitalen infektionen
DE102017113263A1 (de) 2017-06-16 2018-12-20 Lactopia GmbH Pharmazeutische Zusammensetzung enthaltend Bakterienstämme aus der Familie der Lactobacillaceae und Molke
CN118530912B (zh) * 2024-07-17 2024-11-01 山东威曼宠物食品有限公司 一种改善和缓解猫尿道感染的植物乳植杆菌King23及其应用

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL294835A (de) * 1962-07-19 1900-01-01
US3459554A (en) * 1967-01-26 1969-08-05 Kaken Kagaku Kk Process for ripening silages
GB1182463A (en) * 1967-02-18 1970-02-25 Sterwin Ag Improvements in or relating to Pharmaceutical Compositions
US3689640A (en) * 1967-09-28 1972-09-05 Univ Of Nebraska The Antibiotic acidophilin and process of preparing the same
GB1235540A (en) * 1968-12-02 1971-06-16 Armour Pharma Oral preparations containing proteolytic enzymes suitable for pediatric use
DK127268A (de) * 1970-01-12 1900-01-01
US4259314A (en) * 1979-12-10 1981-03-31 Hans Lowey Method and composition for the preparation of controlled long-acting pharmaceuticals
IL60123A (en) * 1980-05-20 1983-05-15 Friedlander Ayalla Pharmaceutical composition for the treatment of bactericidal infections of the urinary and genital tracts comprising lactobacillus acidophilus or doederlein's bacillus
DE3172139D1 (en) * 1981-08-28 1985-10-10 Nestle Sa Pharmaceutical carrier and compositions
JPS5911177A (ja) * 1982-07-12 1984-01-20 Seikenkai 新規乳酸桿菌
DK242083D0 (da) * 1983-05-27 1983-05-27 Hansens Chr Bio Syst Vaginalkapsler
US4592748A (en) * 1984-05-18 1986-06-03 Vortex Research Corp. Yoghurt based douche kit and assembly therefor
CH664497A5 (de) * 1984-08-31 1988-03-15 Solco Basel Ag Vakzine zur behandlung der harnwegsinfektionen.
CH663899A5 (fr) * 1985-03-20 1988-01-29 Nestle Sa Procede pour la preparation d'une composition a base d'un principe actif de faible hydrosolubilite finement divise.
DE3608745A1 (de) * 1985-07-24 1987-01-29 Bayer Ag Bakterizide zubereitungen zur anwendung auf dem gebiet der veterinaermedizin
SE8603338D0 (sv) * 1986-08-07 1986-08-07 Bjorn Andersch Medel for behandling av tillstand i slidan
CH674150A5 (de) * 1987-10-30 1990-05-15 2 Oi Mo G Med I Im N I Pirogov
IT1227154B (it) * 1988-08-05 1991-03-19 A Tosi Farmaceutici S R L Nova Composizioni farmaceutiche per uso ginecologico a base di lattobacilli
US5149532A (en) * 1989-11-01 1992-09-22 Cedars Sinai Medical Center Method of vaccine or toxoid preparation and immunization by colonization with recombinant microorganisms
US5198419A (en) * 1989-12-08 1993-03-30 Immuno Japan Inc. Formulated medicines for enhancing the efficacy of beta-lactam antibiotics in prophylaxis and treatment against infectious disease due to pathogenic bacteria
JPH0678367B2 (ja) * 1990-05-15 1994-10-05 呉羽化学工業株式会社 食物繊維、その製造法及びその食物繊維を含有する生理活性剤
US5464755A (en) * 1994-04-29 1995-11-07 Biolog, Inc. Microbiological medium and method of assay
US5579734A (en) * 1995-02-13 1996-12-03 Muth; Barry A. Rotary valve internal combustion engine

Also Published As

Publication number Publication date
AU2920592A (en) 1993-06-15
DE69232621T2 (de) 2003-02-13
GB9124335D0 (en) 1992-01-08
DE69232621D1 (de) 2002-07-04
EP0613374B1 (de) 2002-05-29
ES2173872T3 (es) 2002-11-01
WO1993009793A1 (en) 1993-05-27
GB2261372A (en) 1993-05-19
US6004551A (en) 1999-12-21
EP0613374A1 (de) 1994-09-07
DK0613374T3 (da) 2002-09-23
US5645830A (en) 1997-07-08
CA2123709A1 (en) 1993-05-27

Similar Documents

Publication Publication Date Title
ATE218062T1 (de) Lactobazillus- und magermilchzusammensetzungenund verfahren zur verhütung der mikrobiellen urogenitalen infektionen
DE69623991D1 (de) Hemmung des bakterienwachstums in absorbierenden gegenständen durch zugabe an deser bakterien
AU5833994A (en) Pharmaceutical and dermocosmetic compositions containing equine colostrum
ATE259145T1 (de) Hydrophile polymermischungen, die zur prävention von hautinfektionen bei kühen verwendet werden
DE69924141D1 (de) Orale verabreichung von laktobacillus zur behandlung und prävention von urogenitalen infektionen
EP0206529A3 (de) Behandlung oraler Krankheiten
CA2099855A1 (en) Antigastritis Agent
MY120038A (en) Method and composition for inhibiting growth of microorganisms including peracetic acid and a non- oxidizing biocide.
FI922825A0 (fi) Menetelmä farmaseuttisen valmisteen valmistamiseksi patogeenisten suolistobakteerien torjumiseksi
EP0280519A3 (en) Bacterial inhibiting compositions and use thereof
ATE217155T1 (de) Homogene und stabile suspension ohne emulgiermittel,verfahren zu ihrer herstellung und ihre verwendung in nahrungsmittelzusammnensetzungen
DK0594590T3 (da) Vombakterie til forebyggelse af akut mælkesyreacidose
HU9700023D0 (en) Pyridyl-thio-compounds, their application again helicobacter bacterium
DE59303372D1 (de) Verfahren und anlage zur regulierung des fettgehaltes von milch und rahm
NO930609L (no) Fremgangsmaate for aa regulere tilveksten i mikrobe- og/eller bakterieflora i papirindustrien
EP0113396A3 (de) Flüssige haftende desinfizierende Zusammensetzungen zur topischen Anwendung und Verfahren zu ihrer Herstellung
ATE205246T1 (de) Molkerei-reinigungssystemverfahren
KR950007861A (ko) 항종양제
DE69322235D1 (de) Thiomarinol-Derivate und Verfahren zu ihrer Herstellung
DE69321911D1 (de) Macrofehlerfreie Zementzusammensetzungen mit verbesserten Eigenschaften und Verfahren zu seiner Herstellung
ATE209647T1 (de) Pyridiniumsalze und ihre verwendung zur bekämpfung von helicobacter-bakterien
CA2115992A1 (en) The uses of aminoalkanolamide esters as processing aids for thermoplastics
Whitehouse et al. Isolation of Simonsiella sp. from a neonate
DE60018919D1 (de) Verwendung von milchsaürebakterien bei der herstellung von fermentierten milchprodukten zur behandlung von verringerten immunitätsebenen
IE880484L (en) Process for the preparation of aromatic diamines containing¹a diorganopolysiloxane group

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee
RZN Patent revoked